Trial site
Clinical Science Institute
- 6running trials
- 14closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Psoriasis10 trials
- Atopic dermatitis (eczema)7 trials
- Chronic spontaneous urticaria1 trial
- Hidradenitis suppurativa1 trial
- Lupus (SLE)1 trial
- Phase
- Phase 312 trials
- Phase 26 trials
- Phase 2/32 trials
- Status
- Completed13 trials
- Active, not recruiting5 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- Amgen3 trials
- Eli Lilly and Company3 trials
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company2 trials
- Pfizer2 trials
- and 6 more
Running trials
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Active, not recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
Closed trials
Completed
A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
Completed
A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026